Facioscapulohumeral Dystrophy clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
Sorry, not currently recruiting here
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
Orange, California and other locations

Last updated: June 23, 2025